CatalystWireBeta

Result of AGM

In brief · summary, not quotable

Verici Dx Plc announced that all resolutions were passed at its Annual General Meeting, with Resolution 1 receiving 84.57% of votes in favour and Resolutions 2 through 5 receiving over 99.7% of votes in favour, indicating strong shareholder support for the company's proposals.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your VRCI notes

Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that at the Annual General Meeting ("AGM") held yesterday, all resolutions were duly passed.

The voting results of the AGM were as follows:

In FavourAgainstWithheld
ResolutionVotes%Votes%Votes
1863,045,02684.57157,508,49115.43501
21,020,180,55099.96371,8530.041,615
31,020,355,87099.98197,6470.02501
41,017,689,28599.732,758,3890.27106,344
51,017,257,97499.693,189,1090.31106,935
Verici Dx plcwww.vericidx.com
Sara Barrington, CEOVia Walbrook PR
Singer Capital Markets (Nominated adviser, Joint Broker)Tel: +44 (0)20 7496 3000
Alex Bond / Russell Cook
Oberon Capital (Joint Broker)Tel: +44 (0)20 3179 0500
Mike Seabrook / Adam Pollock
Walbrook PR (Media & Investor Relations)Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com
Alice Woodings / Rachel BroadMob: +44 (0)7407 804 654 / +44 (0)7747 515 393

Verici Dx

The company is UK headquartered in Cardiff for the UK, and in Franklin, Tennessee for the U.S.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note